Patiromer With or Without Food for the Treatment of Hyperkalemia

Completed · Phase 4

Conditions studied: Hyperkalemia

In brief

The purpose of this study is to evaluate the efficacy and safety of patiromer administered once daily (QD) when given with food compared to without food (experimental treatment group) for the treatment of hyperkalemia (high potassium in the blood).

Key facts

Study ID
NCT02694744
Run by
Relypsa, Inc.
People needed
114
Starts
2016-02-01
Expected to finish
2016-08-01
Last updated by the study team
2021-05-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.